Physician profile
Donald T Hudak
NPI 1396709234
$2,548.23
in general payments reported to CMS, 2019-2025
17 companies · $751 in 2025
The $751 reported for 2025 was more than what a typical Ophthalmic Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.01 · 2020: $113 · 2021: $219 · 2022: $546 · 2023: $72.67 · 2024: $826 · 2025: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,649.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $793.20 | 2020-2023 | Tepezza |
| Amgen INC. | $527.82 | 2024-2025 | Tepezza |
| Alcon Vision LLC | $356.05 | 2022-2025 | Argos, Clareon, Unity |
| Tarsus Pharmaceuticals, INC. | $236.08 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $149.52 | 2024-2025 | |
| Rxsight INC | $121.28 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Abbvie INC. | $101.03 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $70.98 | 2025 | Miebo, Xiidra |
| Regeneron Healthcare Solutions, INC. | $34.73 | 2024 | Eylea Hd |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $24.67 | 2024 | |
| Kerecis Limited | $23.05 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Biotissue Holdings INC. | $20.31 | 2022 | |
| Aerie Pharmaceuticals, INC. | $20.01 | 2019 | |
| Boston Scientific Corporation | $19.77 | 2021 | |
| Eyevance Pharmaceuticals LLC | $18.78 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $17.49 | 2025 | |
| Sight Sciences, INC. | $13.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Hudak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.